Advanced prostate cancer is a heterogenous disease with multiple treatment options. Patients with advanced disease are stratified based evidence of metastasis and sensitivity to hormone therapy. Men with hormone sensitive disease are treated with androgen deprivation therapy and possibly chemotherapy. The treatment options for men with castrate resistant disease are rapidly evolving with multiple recently approved treatment options. Determining the proper sequence and combination of these therapies remains a work in progress.

Original languageEnglish
Pages (from-to)156-161
Number of pages6
JournalMissouri Medicine
Issue number2
StatePublished - Mar 1 2018


Dive into the research topics of 'Treatment of Advanced Prostate Cancer'. Together they form a unique fingerprint.

Cite this